Woodson L C, Weinshilboum R M
Biochem Pharmacol. 1983 Mar 1;32(5):819-26. doi: 10.1016/0006-2952(83)90582-8.
Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurines and thiopyrimidines. Human kidney TPMT was purified over 300-fold and its biochemical properties were determined. TPMT was "soluble" and had a molecular weight of approximately 36,000 daltons as estimated by gel filtration chromatography. The pH optimum of the purified TPMT was 6.7. "True" Km values for 6-mercaptopurine (6-MP) and S-adenosyl-L-methionine (SAM), the two cosubstrates for the reaction, were 0.30 mM and 2.7 microM respectively. "Apparent" Km values for 6-thioguanine and 2-thiouracil, two other methyl acceptor substrates, were 0.55 and 2.0 mM respectively. Aliphatic thiol compounds were either poor substrates for TPMT or were not methylated. S-Adenosyl-L-homocysteine was a competitive inhibitor of TPMT when the varied substrate was SAM, and 6-methylmercaptopurine was a noncompetitive inhibitor with respect to 6-MP. Purified TPMT was neither activated nor inhibited by 1 mM Ca2+ or Mg2+, but exposure to reagents such as N-ethylmaleimide and ethacrynic acid that interact with sulfhydryl groups inactivated the enzyme. Tropolone inhibited TPMT with a Ki of approximately 0.85 mM. Finally, human kidney TPMT activity could be distinguished from human kidney thiol methyltransferase (EC 2.1.1.9) activity on the basis of subcellular distribution, substrate specificity, kinetic characteristics and differential sensitivity to inhibitors.
硫嘌呤甲基转移酶(TPMT)催化硫嘌呤和硫嘧啶的S-甲基化反应。人肾TPMT被纯化了300多倍,并测定了其生化特性。TPMT是“可溶性的”,通过凝胶过滤色谱法估计其分子量约为36,000道尔顿。纯化后的TPMT的最适pH值为6.7。该反应的两种共底物6-巯基嘌呤(6-MP)和S-腺苷-L-甲硫氨酸(SAM)的“真实”Km值分别为0.30 mM和2.7 microM。另外两种甲基受体底物6-硫鸟嘌呤和2-硫尿嘧啶的“表观”Km值分别为0.55和2.0 mM。脂肪族硫醇化合物要么是TPMT的不良底物,要么不被甲基化。当可变底物为SAM时,S-腺苷-L-高半胱氨酸是TPMT的竞争性抑制剂,而6-甲基巯基嘌呤相对于6-MP是非竞争性抑制剂。纯化后的TPMT既不被1 mM Ca2+或Mg2+激活也不被其抑制,但暴露于与巯基相互作用的试剂如N-乙基马来酰亚胺和依他尼酸会使该酶失活。托酚酮抑制TPMT,其抑制常数Ki约为0.85 mM。最后,基于亚细胞分布、底物特异性、动力学特征以及对抑制剂的不同敏感性,可以将人肾TPMT活性与人肾硫醇甲基转移酶(EC 2.1.1.9)活性区分开来。